{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:34:17Z","timestamp":1782236057072,"version":"3.54.5"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1053\/j.semnuclmed.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T05:58:00Z","timestamp":1623823080000},"page":"4-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Clinical Management of COVID-19 Patients \u2013 An Update"],"prefix":"10.1053","volume":"52","author":[{"given":"Martin","family":"M\u00f8lhave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Agergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wejse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0001","series-title":"Weekly Epidemiological Update on COVID-19","year":"2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0003","first-page":"1","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0004","unstructured":"World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Switzerland: WHO Geneva, 2020"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0005","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0006","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/ije\/dyaa140","article-title":"Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort","volume":"49","author":"Reilev","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0007","series-title":"Beregning af Worst Case Scenario for COVID-19 i Danmark","author":"Simonsen","year":"2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249090","article-title":"Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis","volume":"16","author":"Alene","year":"2021","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0009","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0010","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.2021.5612","article-title":"Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers","volume":"325","author":"Havervall","year":"2021","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0011","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0012","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: Prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0013","first-page":"1","article-title":"Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19","volume":"2","author":"Struyf","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0014","article-title":"Guidelines for Frontline Health Care Staff Safety for COVID-19","volume":"11","author":"Baker","year":"2020","journal-title":"J Prim Care Community Health"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0015","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.2020.8259","article-title":"Interpreting diagnostic tests for SARS-CoV-2","volume":"323","author":"Sethuraman","year":"2020","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40364-020-00217-0","article-title":"A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)","volume":"8","author":"Danwang","year":"2020","journal-title":"Biomark Res"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jemermed.2021.03.012","article-title":"Soluble urokinase plasminogen activator receptor as a decision marker for early discharge of patients with COVID-19 symptoms in the emergency department","author":"Stauning","year":"2021","journal-title":"J Emerg Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0018","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1148\/radiol.2020200823","article-title":"Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT","volume":"296","author":"Bai","year":"2020","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0019","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1148\/radiol.2020200463","article-title":"Chest CT findings in Coronavirus Disease-19 (COVID-19): Relationship to duration of infection","volume":"295","author":"Bernheim","year":"2020","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0021","unstructured":"World Health Organization (WHO). COVID-19 Clinical management: Living Guidance; 2021. https:\/\/www.who.int\/publications-detail-redirect\/WHO-2019-nCoV-clinical-2021-1. Accessed May 30, 2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0022","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0023","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients in severe SARS-CoV-2 infection: A multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Medicine"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0024","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0025","unstructured":"Interim clinical guidance for management of patients with Confirmed Coronavirus Disease (COVID-19). Center of Disease Control, Atlanta USA: 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-guidance-management-patients.html. Accessed May 20, 2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0026","unstructured":"World Health Organization (WHO). Corticosteroids for COVID-19. Living Guidance. WHO, Geneva, Switzerland; 2020. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Corticosteroids-2020.1. Accessed May 30, 2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0027","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0028","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"ACTT-1 study group members. remdesivir for the treatment of Covid-19 - Final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2021.06.004_bib0029","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N Engl J Med. 11. februar"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0030","unstructured":"World Health Organization (WHO). Therapeutics and COVID-19: Living Guideline: WHO, Geneva, Switzerland: 2021. https:\/\/www.who.int\/publications-detail-redirect\/WHO-2019-nCoV-therapeutics-2021.1. Accessed May 25, 2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0031","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N Engl J Med. 5"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0032","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: A randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0033","unstructured":"Danish Society for Infectious Diseases. Guideline for the Treatment of Hospitalized Adult Patients With COVID-19. Danish Society for Infectious Diseases, Copenhagen, Denmark: 2021. https:\/\/infmed.dk\/site\/tools\/download.php?UID=7465560a5bf910e5ea236a3b4ed81d0cf818a843. Accessed May 20, 2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0034","unstructured":"European Medicines Agency. Veklury. Published 2020. EMA, Amsterdam, Netherlands. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/veklury. Accessed September 21, 2020."},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0035","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with Covid-19","volume":"383","author":"Stone","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0036","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamainternmed.2020.6615","article-title":"Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: A randomized clinical trial","volume":"181","author":"Salvarani","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0037","doi-asserted-by":"crossref","first-page":"n84","DOI":"10.1136\/bmj.n84","article-title":"Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: Randomised controlled trial","volume":"372","author":"Veiga","year":"2021","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0038","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0039","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe Covid-19 pneumonia","volume":"22","author":"Rosas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0040","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with Covid-19","volume":"384","author":"Gordon","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0041","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0042","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","article-title":"Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19","volume":"383","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0043","doi-asserted-by":"crossref","first-page":"m1849","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: Open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0044","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(20)31862-6","article-title":"Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): A randomised clinical trial","volume":"396","author":"Furtado","year":"2020","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0045","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of hydroxychloroquine in hospitalized patients with Covid-19","volume":"383","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0046","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0047","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with Covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0048","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamainternmed.2020.5503","article-title":"m.fl. Effect of recombinant human granulocyte colony-stimulating factor for patients with coronavirus disease 2019 (COVID-19) and lymphopenia: A randomized clinical trial","volume":"181","author":"Cheng","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0049","first-page":"m4232","article-title":"Convalescent plasma in the management of moderate covid-19 in adults in India: Open label phase II multicentre randomized controlled trial (PLACID Trial)","volume":"371","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0050","first-page":"CD013600","article-title":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: A living systematic review (Review)","volume":"5","author":"Kl","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0051","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19","volume":"324","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0052","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","article-title":"SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: A systematic review and meta-analysis","volume":"2","author":"Cevik","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0053","doi-asserted-by":"crossref","first-page":"m3862","DOI":"10.1136\/bmj.m3862","article-title":"Virology, transmission, and pathogenesis of SARS-CoV-2","volume":"371","author":"Cevik","year":"2020","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0054","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1056\/NEJMc2027040","article-title":"Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19","volume":"384","author":"Kim","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0055","doi-asserted-by":"crossref","first-page":"m1443","DOI":"10.1136\/bmj.m1443","article-title":"Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study","volume":"369","author":"Zheng","year":"2020","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0056","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1038\/s41467-020-19057-5","article-title":"SARS-CoV-2 viral load is associated with increased disease severity and mortality","volume":"11","author":"Fajnzylber","year":"2020","journal-title":"Nat Commun"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0057","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of Viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0058","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s43018-021-00191-y","article-title":"Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy","volume":"2","author":"Thakkar","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0059","unstructured":"Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COVTM (casirivimab with imdevimab) Significantly Reduced Progression to Symptomatic COVID-19 | Regeneron Pharmaceuticals Inc. Regeneron Pharmaceuticals, New York, USA: 2021.https:\/\/investor.regeneron.com\/index.php\/news-releases\/news-release-details\/phase-3-treatment-trial-recently-infected-asymptomatic-patients\/. Accessed May 30, 2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0060","unstructured":"Phase 3 Trial Shows REGEN-COVTM (casirivimab with imdevimab) Antibody Cocktail Reduced Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients | Regeneron Pharmaceuticals Inc. 2021. https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/phase-3-trial-shows-regen-covtm-casirivimab-imdevimab-antibody\/"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0061","unstructured":"CASIRIVIMAB WITH IMDEVIMAB ANTIBODY COCKTAIL FOR COVID-19 PREVENTION: INTERIM RESULTS [Internet]. CROI Conference. 2021. https:\/\/www.croiconference.org\/abstract\/casirivimab-with-imdevimab-antibody-cocktail-for-covid-19-prevention-interim-results\/. Accessed May 29, 2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0062","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/infdis\/jiaa446","article-title":"Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy","volume":"222","author":"Helleberg","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0063","unstructured":"Senf\u00f8lger efter COVID-19, Sundhedsstyrelsen 2021, https:\/\/www.sst.dk\/da\/Udgivelser\/2020\/Senfoelger-efter-COVID-19. Accessed May 22, 2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0064","unstructured":"COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Execellence. NICE, London, UK: 2021. https:\/\/www.nice.org.uk\/guidance\/ng188. Accessed May 25, 2021"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0065","doi-asserted-by":"crossref","first-page":"m4938","DOI":"10.1136\/bmj.m4938","article-title":"NICE guideline on long covid. Research must be done urgently to fill the many gaps in this new \u201cliving guideline","volume":"371","author":"Sivan","year":"2020","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0066","doi-asserted-by":"crossref","first-page":"ofab042","DOI":"10.1093\/ofid\/ofab042","article-title":"Persistent symptoms in patients recovering from COVID-19 in Denmark","volume":"8","author":"Leth","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0067","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00205-2021","article-title":"Descriptive analysis of long COVID sequela identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients","author":"Johnsen","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0068","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0069","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequalae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0070","first-page":"1","article-title":"F-FDG brain PET hypometabolism in patients with long COVID","author":"Guedj","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100484","article-title":"Cerebral micro-structural changes in COVID-19 patients \u2013 An MRI-based 3-month follow-up study","volume":"25","author":"Lu","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0072","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.clinph.2021.04.009","article-title":"Myopathic changes in patients with long-term fatigue after COVID-19","volume":"132","author":"Agergaard","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0073","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.euroneuro.2021.03.019","article-title":"Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables","volume":"46","author":"Miskowiak","year":"2021","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0074","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","article-title":"Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0075","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0076","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jaci.2020.12.641","article-title":"Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction","volume":"147","author":"Alfred B Addison","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0077","article-title":"Comprehensive health assessment three months after recovery from acute COVID-19","author":"Borst","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0078","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus Disease 2019 (COVID-19)","author":"Puntmann","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0079","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.7326\/L20-0845","article-title":"Myasthenia gravis associated with SARS-CoV-2 infection","volume":"173","author":"Restivo","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0080","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12020-020-02364-8","article-title":"Thyroid disease in the time of COVID-19","volume":"68","author":"Dworakowska","year":"2020","journal-title":"Endocrine"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0081","series-title":"Support for Rehabilitation: Self-Management after COVID-19 Related Illness","year":"2020"},{"key":"10.1053\/j.semnuclmed.2021.06.004_bib0082","unstructured":"CDC guidelines coming along 2021. https:\/\/www.medscape.com\/viewarticle\/950159. Accessed May 28, 2021"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299821000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299821000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:37:41Z","timestamp":1757543861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299821000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0001299821000362"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.06.004","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Management of COVID-19 Patients \u2013 An Update","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}